No association was observed between green tea supplementation and the outcomes evaluated in the meta-analyses, and the findings should be interpreted with caution because of methodological heterogeneity, risk of bias, and the low or very low certainty of the evidence.
Abstract
Green tea catechins have chemopreventive potential; however, the clinical evidence remains inconsistent. This review evaluated the effects of supplementation with green tea derivatives on chemoprevention at different stages of carcinogenesis. PubMed, Embase, Web of Science, Scopus, the Cochrane Library, CINAHL, and Google Scholar were searched for randomised and non-randomised clinical trials in adults. Random-effects meta-analyses were used to estimate relative risks (RRs) and 95% confidence intervals (95% CIs). Risk of bias and certainty of the evidence were assessed using RoB 2, ROBINS-I, and GRADE. Of the 7089 records identified, 19 studies, comprising a total of 3121 participants, were included. Nine studies were included in the meta-analyses. No statistically significant associations were observed for regression of cervical lesions (RR = 2.40; 95% CI: 0.36-16.23), HPV clearance (RR = 1.19; 95% CI: 0.68-2.07), prostate cancer incidence (RR = 0.52; 95% CI: 0.22-1.23), or colorectal adenoma recurrence (RR = 0.71; 95% CI: 0.50-1.00). The qualitative synthesis showed heterogeneous findings, including favourable effects on some biomarkers. The certainty of the evidence was rated as low or very low. Although no association was observed between green tea supplementation and the outcomes evaluated in the meta-analyses, the findings should be interpreted with caution because of methodological heterogeneity, risk of bias, and the low or very low certainty of the evidence. Clinical trials with larger sample sizes and populations that are more comparable in terms of the type and stage of carcinogenesis are needed to clarify the chemopreventive potential of green tea supplementation.
Aim: The association between green tea consumption and hepatocellular carcinoma (HCC) risk remains controversial. This meta-analysis aimed to quantify this association using rigorous epidemiological evidence.
Methods: Six electronic databases (PubMed, Embase, Cochrane Library, SinoMed, CNKI, and Wanfang Data) were sea...
Si-Ting Ling, Lu-Ze Xie, Wen-Bin Liu et al.· Hepatoma Research· 0 citations
Background: Nutraceutical use is common among men with prostate cancer, but its clinical efficacy remains uncertain. We systematically reviewed randomized controlled trials evaluating orally administered nutraceutical and defined dietary interventions after prostate cancer diagnosis. Methods: PubMed, MEDLINE, and Embas...
Hao-Yue Zhang, Shao-Ting Zhang, Jonathon Carll et al.· Société Internationale d'Uro...· 0 citations
INTRODUCTION
Estrogen exposure is a known risk factor for breast cancer. Phytoestrogens, plant-derived compounds found in the diet, have a structure similar to estradiol. Observational studies suggest that they are associated with a reduced risk of breast cancer recurrence. The objective of this systematic review is to...
Laurence Poirier, C. Diorio· Bulletin du Cancer· 0 citations
Background: Although numerous observational studies suggest that higher vitamin D levels are associated with a reduced risk of breast cancer, the overall evidence remains inconclusive. This study aimed to comprehensively evaluate this association through a systematic review and meta-analysis.Methods: A systematic liter...
Ghazal Mehranpour, Maryam Beigrezaee, Atefeh Shahryari Atashgah et al.· Archives of Breast Cancer· 0 citations
BACKGROUND
Alcohol consumption is a known risk factor for cancer, but different alcoholic beverages may be differently associated with cancer risk. Wine is a complex hydro-alcoholic solution containing several compounds with potential anti-carcinogenic properties. This umbrella review aimed to summarize the available e...
C. Bertola, L. Conciarelli, Pier Paolo Russo et al.· Cancer Epidemiology· 0 citations
The pooled analysis supports an association between dietary inflammatory potential and oral cancer risk and suggests that dietary interventions aimed at reducing inflammation may be a viable strategy for oral cancer prevention.
Bin Li, Jie Chen, Peng-Kui Yu· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.